Rapid method for the measurement of methylprednisolone and its hemisuccinate in plasma and urine following "pulse therapy" by high-performance liquid chromatography.
A rapid method for the measurement of methylprednisolone and its 21-hemisuccinate ester in plasma and urine following high dose pulse therapy is described. The drugs were extracted using Extrelut columns, eluted with ethyl acetate which was evaporated to dryness and the residue was reconstituted in chromatographic mobile phase. High-performance liquid chromatography was performed on a reversed-phase column using a mobile phase of acetonitrile-acetate buffer with detection at 251 nm. No interference from any drugs or endogenous compounds has been observed. The method has been used to analyse over 200 plasma and 150 urine samples from patients with rheumatoid disease or renal failure who have received high dose methylprednisolone hemisuccinate infusions.
D058186:Acute Kidney Injury / Q000097:blood / Q000188:drug therapy / Q000652:urine; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007263:Infusions, Parenteral; D007700:Kinetics; D008775:Methylprednisolone / Q000031:analogs & derivatives* / Q000097:blood* / Q000627:therapeutic use / Q000652:urine; D008776:Methylprednisolone Hemisuccinate / Q000097:blood* / Q000652:urine
D008776:Methylprednisolone Hemisuccinate; D008775:Methylprednisolone